Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Y-3 for Injection”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)Study completedNCT07068841
What this trial is testing

Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants

Who this might be right for
Pharmacokinetic ProfilesY-3 for InjectionDrug-drug Interaction+4 more
Neurodawn Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Not Yet RecruitingNCT07055412
What this trial is testing

Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects

Who this might be right for
Pharmacokinetic DifferencesY-3Saftey+3 more
Neurodawn Pharmaceutical Co., Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT06517173
What this trial is testing

Y-3 for Injection in the Treatment of Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Beijing Tiantan Hospital 998